This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Research Developments in Psoriasis Treatment

Research Developments in Psoriasis Treatment

Format

Webcast

Time to Complete

1.50 hours

Released

June 30, 2017

Expires

June 29, 2018
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 CreditTM

Accredited Provider

Provided by the Annenberg Center for Health Sciences at Eisenhower

Commercial Supporter

This activity is supported by an independent educational grant from Novartis.

This activity is supported by an independent educational grant from Celgene.

Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Program Description

Mark Lebwohl, MD, Waldman Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, provides his perspectives on key posters presented at the American Academy of Dermatology annual meeting on the management of patients with moderate-to-severe psoriasis.

Listen to summaries of 10 posters presented at the meeting.
Proceed at your own pace and in any order. Each poster perspective is about 5 minutes.
Compare your knowledge against your peers.
Download summary slides to your library.

Content areas include:

  • Plaque psoriasis
  • Psoriasis
  • Psoriatic arthritis

Intended Audience

This activity was developed for dermatologists, advanced nurse practitioners, physician assistants, and other health care professionals who have an interest in patients with moderate-to-severe psoriasis.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Summarize the latest research developments in the treatment of moderate-to-severe psoriasis
  • Incorporate evidence-based research into clinical practice

Conflict Of Interest Disclosure Policy

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

Faculty

Mark Lebwohl, MD
Professor and System Chair, Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Dr. Lebwohl, MD discloses the following:
Research Support: AbbVie, Amgen, Boehringer Ingleheim, Celgene, Eli Lilly, Janssen, Kadmon, LEO Pharma, Medimmune/Astra Zeneca, Novartis, Pfizer, UCB Pharma, and Vidac Pharma

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.

Disclaimer

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

Instructions

Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.

Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.

Contact Information

For help or questions about this Internet activity, please contact Annenberg Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday

Privacy Policy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

myCME privacy policy
Add to Queue